Molecular mechanisms of west nile virus pathogenesis in brain cells

Emerging Infectious Diseases

Volumn 11, Issue 4, 2005, Pages 629-632

  Koh, Wee Lee ^a   Ng, Mah Lee ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BRAIN CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLIOMA CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; NEUROPATHOLOGY; NONHUMAN; VIRUS INFECTION; VIRUS PATHOGENESIS; WEST NILE FLAVIVIRUS;

EID: 16244373357     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1104.041076     Document Type: Article

References (15)

1. Sampson BA, Ambrosi C, Charlot A, Reiber K, Veress JF. The pathology of human West Nile virus infection. Human Pathol. 2000;31:527-31.
2. Solomon T, Winter PM. Neurovirulence and host factors in flavivirus encephalitis-evidence from clinical epidemiology. Arch Virol Suppl. 2004;18:61-70.
3. Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol. 2003;77:11822-32.
4. Hosack DA, Dennis G, Sherman BT, Lane H, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:R70.
5. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14:778-809.
6. Salmaggi A, Gelati M, Dufour A, Corsini E, Pagano S, Baccalini R, et al. Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J Interferon Cytokine Res. 2002;22:631-40.
7. Shrestha B, Diamond MS. Role of CD8+ T cells in control of West Nile virus infection. J Virol. 2004;78:8312-21.
8. Grant R, Kapoor V. Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels. Biochem Pharmacol. 2003;66:1033-6.
9. Bottazzi B, Vouret-Craviari V, Bastone A, de Gioia L, Matteucci C, Peri G, et al. Multimer formation and ligand recognition by the long pentraxin PTX3: similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem. 1997;272:32817-23.
10. Chu JJH, Ng ML. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J Gen Virol. 2003;84:3305-14.
11. Schapira AH. Mitochondrial dysfunction in neurodegenerative disorders. Biochim Biophys Acta. 1998;1366:225-33.
12. Burton JM, Kern RZ, Halliday W, Mikulis D, Brunton J, Fearon M, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci. 2004;31:185-93.
13. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer. 2003;3:193-202.
14. Kim SH, Fountoulakis M, Cairns N, Lubec G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl. 2001;61:223-35.
15. Kim SH, Shim KS, Lubec G. Human brain nascent polypeptide-associated complex alpha subunit is decreased in patients with Alzheimer's disease and Down syndrome. J Investig Med. 2002;50:293-301.